Alkylresorcinols

ID144
NameAlkylresorcinols
Synonyms
StructureThumb
Description
GroupPolyphenols
Sub-groupAlkylresorcinols
Exposure sourceDiet
Use
CAS number
PubChem ID
ChEBI ID
FooDB ID
HMDB ID

Biomarker measurements

Biomarker concentration values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
10470AllAdults from the university campus area in UppsalaSwedenSEbaselinePlasma, fastingGC-MSAlkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
5173.057.092.0nmol/L73.0 nmol/LCrudeAndersson 2011
10540AllAdults from the university campus area in UppsalaSwedenSE3 monthsPlasma, fastingGC-MSAlkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
5184.066.0107.0nmol/L84.0 nmol/LCrudeAndersson 2011
12590AllCases and controls post-menopausal women in a case-control study on endometrial cancerDenmarkDKDiet, Cancer and Health studyPlasma, non-fastingGC-MSAlkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
360115.0112.078.0106.9nmol/L115.0 nmol/L78.0 nmol/LCrudeLandberg 2011
32920AllSubjects from the Nestlé Research CentreSwitzerlandCHPlasma, fastingGC-MSAlkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
2955.826.816.7108.38nmol/L55.8 nmol/LCrudeRoss 2009
34550All [by diet]Postmenopausal and premenopausal women living in the Helsinki areaFinlandFIPlasma, fastingGC-MSAlkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
5665.534.7nmol/L65.5 nmol/LCrudeAubertin-Leheudre 2008
34690VegetariansPostmenopausal and premenopausal women living in the Helsinki areaFinlandFIPlasma, fastingGC-MSAlkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
2060.926.6nmol/L60.9 nmol/LCrudeAubertin-Leheudre 2008
34830OmnivoresPostmenopausal and premenopausal women living in the Helsinki areaFinlandFIPlasma, fastingGC-MSAlkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
3667.337.5nmol/L67.3 nmol/LCrudeAubertin-Leheudre 2008
185540AllParticipants without a history of heart diseaseGermanyDEEPIC-Potsdam (European Prospective Investigation into Cancer and Nutrition)baselinePlasma, fastingGC-MSAlkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
10048.841.557.3nmol/L48.8 nmol/LCrudeMontonen 2010
185600AllParticipants without a history of heart diseaseGermanyDEEPIC-Potsdam (European Prospective Investigation into Cancer and Nutrition)4 monthsPlasma, fastingGC-MSAlkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
10048.741.457.4nmol/L48.7 nmol/LCrudeMontonen 2010
190780AllResidents of the Vasterbotten regionSwedenSEVIP cohort (Vasterbotten Intervention Project)baselinePlasma, fastingGC-MSAlkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
7345.338.653.2nmol/L45.3 nmol/LCrudeLandberg 2013

Intake values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionIntake toolIntake food coverageIntake time coverageIntake assessmentCompoundCompound detailSupplement intakes included?Measurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
10220AllAdults from the university campus area in UppsalaSwedenSEbaselineSwedish National Food AdministrationWeighed Dietary record (3-day)Alkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
7236.030.0mg/day36.0 mg/dayCrudeAndersson 2011
10400AllAdults from the university campus area in UppsalaSwedenSE3 monthsSwedish National Food AdministrationWeighed Dietary record (3-day)Alkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
7234.028.0mg/day34.0 mg/dayCrudeAndersson 2011

Correlation values

Reproducibility values

IDMst. IDSubject groupPopulationCountryCountry codeCohortTime definitionBiological specimenExperimental methodBiomarkerBiomarker detailArithmetic meanGeometric meanMedianUnitAdjusted onReproducibility sizeICCICC 95% CI lowerICC 95% CI upperCV% WSCV% BSVAR WSVAR BSPublication
91072AllAdults from the university campus area in UppsalaSwedenSEbaseline; 3 monthsPlasma, fastingGC-MSAlkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Heptadecylresorcinol (C17:0) / 5-n-Heneicosylresorcinol (C21:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
nmol/L510.470.270.67Andersson 2011
24618548AllParticipants without a history of heart diseaseGermanyDEEPIC-Potsdam (European Prospective Investigation into Cancer and Nutrition)baseline; 4 monthsPlasma, fastingGC-MSAlkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
nmol/L1000.420.250.57Montonen 2010
60619070AllResidents of the Vasterbotten regionSwedenSEVIP cohort (Vasterbotten Intervention Project)baseline; 2 yearsPlasma, fastingGC-MSAlkylresorcinols5-n-Heneicosylresorcinol (C21:0)
5-n-Heptadecylresorcinol (C17:0)
5-n-Nonadecylresorcinol (C19:0)
5-n-Pentacosylresorcinol (C25:0)
5-n-Tricosylresorcinol (C23:0)
nmol/L730.540.380.69Landberg 2013